Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan
· Delayed Price · Currency is TWD 21.40
+0.10 (0.47%)
Apr 29, 2026, 11:51 AM CST
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 633.12 million as of April 29, 2026. Its market cap has decreased by -9.69% in one year.
Market Cap
633.12M
Enterprise Value
529.57M
Revenue
230.06M
Ranking
n/a
PE Ratio
20.87
Stock Price
21.40
Market Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 633.12M, a decrease of -67.38%. That is a compound annual growth rate of -17.52%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Golden Biotechnology | 562.93M |
| UniPharma | 445.54M |
| Mediera | 979.41M |
| Original BioMedicals | 1.01B |
| Prince Pharmaceutical | 1.04B |
| Anxo Pharmaceutical | 1.07B |
| Excelsior Biopharma | 1.18B |
| DV Biomed | 1.20B |